Articles & posters

Explore a selection of recent articles and posters our company and collaborators have generated.

The opinions and conclusions expressed in the following publications are those of the individual authors and do not necessarily reflect the views and opinions of Biocartis and/or its employees.

Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day

Lambros et al. - J Clin Pathol. - June 2017

Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view

Le Flahec et al. - J Clin Pathol. - July 2017

Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers

Sadlecki et al. - Tumour Biol. - May 2017

Biocartis Idylla proves Fast and Accurate in Detecting Oncogenic KRAS and EGFR Mutations in Paraffin Embedded Tumor Samples

Brohawn et al. - J Diagn Tech Biomed Anal - December 2018

Evaluation of the Idylla system to detect the EGFRT790M mutation using extracted DNA

Bocciarelli et al. - Pathol Res Pract. - January 2020 Jan

Rapid fully-automated assay for routine molecular diagnosis of BRAF mutations for personalized therapy of low grade gliomas

Merlin et al. - Pediatr Hematol Oncol. - Februarary 2020